New report assesses open access in biomedical research across Europe
The European Science Foundation’s (ESF) membership organisation for all medical research councils in Europe, the European Medical Research Councils (EMRC) has released an ESF-EMRC Science Policy Briefing (SPB) entitled ‘Open Access in Biomedical Research’ highlighting the need to accelerate the adoption of open access to research articles in the biomedical sciences across Europe.
“The Internet and the technological developments that have arisen from it in recent years have the potential to radically change science publishing and maximise the impact of research” said Professor Pär Omling, ESF President and Science Europe Vice-President.
He continued: “We envisage a full open access future – one in which all published research generated by science researchers in the European Union is immediately available online and accessible by all.”
EACR was pleased to be represented on the expert panel that produced the briefing.
The Science Policy Briefing can be viewed here or a PDF version is available from the Documents Library of the EACR Members Area.
The ESF-EMRC Science Policy Briefing provides three key recommendations for the adoption of open access policy:
1. There is a moral imperative for open access
Research papers should be made freely available to all to read, use and re-use, with appropriate acknowledgement, in order to maximise the value of biomedical research, build on the body of knowledge, accelerate the process of discovery and improve human health.
2. Individual agencies must work together to raise awareness of the moral imperative for open access
Agencies and organisations that fund and perform research, libraries, publishers and researchers must work collectively to raise awareness of the moral imperative for open access publishing. Enhanced efforts towards national, European and international partnerships are the basis for the successful achievement of open access to research outputs.
3. All research stakeholders should work together in order to support the extension of Europe PubMed Central into a Europe-wide PubMed Central
In order to facilitate discoveries and innovation in biomedical research, research stakeholders should collaborate to establish a Europe-wide repository in biomedicine as a partner site to the US equivalent PubMed Central. The recently rebranded Europe PubMed Central represents a valuable means to achieving this goal, provided that the diversity of European partner mandates and policies can be integrated.
Professor Josef Syka, Chair of the Science Policy Briefing and EMRC Core Group member, commented: “The turnover of information in biomedical sciences is very fast, so rapid delivery of information is needed at a fair price. Open access publishing has the potential to revolutionise the way in which biomedical scientists publish and access the latest results. The EMRC supports open access publishing as the ultimate goal to maximise the discoverability process, the access to and the re-use of biomedical research results in Europe.”
ecancermedicalscience is the platinum open-access journal from ecancer, listed in PubMed.
(29 Jul 2016)